Resolvin D4

• Description :

  Resolvin D4 (RvD4), a specialized proresolving mediator, can be produced in bioactive levels during S. aureus infection[1].

• Product Name Alternative :

  RvD4

• UNSPSC :

  12352211

• Hazard Statement :

  H225, H319

• Target :

  Bacterial

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/resolvin-d4.html

• Concentration :

  265.61 μM * 250 μL in Ethanol

• Purity :

  96.8

• Solubility :

  10 mM in DMSO

• Smiles :

  CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCC(O)=O

• Molecular Formula :

  C22H32O5

• Molecular Weight :

  376.49

• Precautions :

  H225, H319

• References & Citations :

  [1]Jeremy W Winkler, et al. Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance. Sci Rep. 2016 Jan 8:6:18972.|[2]Deya Cherpokova, et al. Resolvin D4 attenuates the severity of pathological thrombosis in mice. Blood. 2019 Oct 24;134 (17) :1458-1468.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  Solution, -20°C, 2 years

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1025684-60-9]